바이오테크 보도자료
-
- Publication of provisional end result for Vifor Pharma tender offer: Participation rate of 94 percent
- Regulatory News: This press release features multimedia. View the full release here: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USO...
- 2022년 03월 23일
-
- Alchemab Selected to Access NVIDIA Cambridge-1 Supercomputer to Advance Machine Learning Enabled Antibody Discovery
- Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire-based patient stratification tools, has been selected by NVIDIA to harness the power of the ...
- 2022년 03월 23일
-
- In a World First, Yokogawa and JSR Use AI to Autonomously Control a Chemical Plant for 35 Consecutive Days
- Yokogawa Electric Corporation (TOKYO: 6841) and JSR Corporation (JSR, TOKYO: 4185) announce the successful conclusion of a field test in which AI was used to autonomously run a chemical plant for 35 days, a world first*1. This test confirmed that ...
- 2022년 03월 22일
-
- Innovation: The Key to VOOPOO’s Leapfrog Development
- VOOPOO, a leading vape manufacturer, recently released a review on its development, revealing the underlying driving force of its success against the market backdrop of complicated international relationships, rising operation cost, intensifying c...
- 2022년 03월 17일
-
- More Than Half of Physicians Have Been Asked By Patients for an Unapproved COVID-19 Treatment
- A new survey from Sermo, a physician-first online community and leader in global HCP insights, found that physicians are facing a challenging onslaught of COVID-19 vaccine and treatment misinformation as reported by 3,600+ doctors around the world...
- 2022년 03월 17일
-
- Arthur D. Little Promotes Nine New Partners Across Global Offices
- Arthur D. Little (ADL) today announced the promotion of nine of its consultants to the rank of Partner across a number of its global offices. Each new Partner has demonstrated their commitment to ADL, passion and dedication to the industries and c...
- 2022년 03월 16일
-
- Encina Announces $55 Million of Committed Financing Supported by IMM Investment Global Limited
- Encina Development Group (“Encina” or the “Company”), a producer of circular chemicals from waste materials, announced today that it has secured a total of $55 Million of equity capital which included participation from institutional investors IMM...
- 2022년 03월 15일
-
- Join KOREA PACK & ICPI WEEK 2022 to Be Held June 14 - 17, KINTEX, Korea!
- KOREA PACK and ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week), the largest packaging, cosmetic and pharmaceutical exhibition in Korea, will be held at KINTEX from June 14th to 17th as hybrid events hosted by Kyungyon Exhibition Corp. ...
- 2022년 03월 14일
-
- Blood Cancer Biomarkers Market: Why Is It Expected That The Asian Market Will Outperform Others, Detailed Study By Fact.MR
- According to Fact.MR’s Study, the cancer biomarkers market revenue is anticipated to surpass US$ 33 Bn by 2031, representing a 3x increase from 2020. Presently, the market is valued at a little above US$ 11 Bn. The increasing prevalence of debilit...
- 2022년 03월 11일
-
- Alvotech Resolves U.S. Patent and Trade Secret Disputes with AbbVie, Securing U.S. Rights for Alvotech’s Proposed High-Concentration Biosimilar (AVT02) for Humira®
- Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, announced today that is has executed a U.S. settlement agreement with AbbVie ...
- 2022년 03월 10일
-
- Sodium Lactate Market Latest Trends, Demand, Growth, Opportunities & Outlook Till 2031: Future Market Insights
- Sodium lactate market revenue totaled US$ 158.7 Mn for 2021, according to a study by Future Market Insights (FMI). The overall sodium lactate sales are expected to reach US$ 368.3 Mn by 2031, growing at a CAGR of 8.8% for 2021 - 2031. Sodium lacta...
- 2022년 03월 10일
-
- ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial for Opioid Sparing in Participants with Radiculopathic Pain
- ANANDA Scientific Inc., a biotech pharmaceutical company, and NYU Grossman School of Medicine today announced that the first patient has been enrolled in a clinical trial evaluating Nantheia™ A1002N5S, an investigational drug using cannabidiol in ...
- 2022년 03월 09일
전시회
